NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Mesoblast Gets FDA Nod for Extra Quality Check on Ryoncil

Mesoblast received FDA approval for a new TIBA assay to check strength and stability of every commercial Ryoncil batch as manufacturing scales.

Mesoblast Gets FDA Nod for Extra Quality Check on Ryoncil
Credit: Mesoblast
Already have an account? Sign in.
09/24/2026 · 7:41 AM
MESO
/ Don’t stop at just one post.

Related↓

Mesoblast’s Potential Blockbuster Back Pain Therapy Moves Closer as Phase 3 Treatment Completes
08/17/2026 · 1:24 PM

Mesoblast’s Potential Blockbuster Back Pain Therapy Moves Closer as Phase 3 Treatment Completes

Mesoblast completes treatment of 350 patients in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain due to degenerative disc disease. Results expected mid-2027.

/ Subscriber only
/ Read more

Feed↓

QNX Drives BlackBerry’s Q2 Beat and Higher FY2027 Outlook
Featured/ 09/24/2026 · 8:07 AM

QNX Drives BlackBerry’s Q2 Beat and Higher FY2027 Outlook

BlackBerry beat Q2 revenue and EPS estimates and raised FY2027 guidance after a record QNX quarter and a $100M Coretura design win.

/ Subscriber only
FDA Signs Off on aTyr’s Revised Phase 3 Plan in Pulmonary Sarcoidosis
09/24/2026 · 7:19 AM

FDA Signs Off on aTyr’s Revised Phase 3 Plan in Pulmonary Sarcoidosis

After EFZO-FIT missed, aTyr has FDA alignment on a narrower Phase 3 using FVC. Cash funds operations into 2028, but not the new trial.

/ Subscriber only
JPMorgan Turns Bullish on CoreWeave as Wall Street Stays Split on Funding Risks
09/24/2026 · 6:51 AM

JPMorgan Turns Bullish on CoreWeave as Wall Street Stays Split on Funding Risks

Demand is tight; short-term GPU contracts are pricing at a premium.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe